



CONGENITAL HEART DISEASEThe Norwood procedure using a right ventricle–pulmonary
artery conduit: Comparison of the right-sided versus left-sided
conduit position
David J. Barron, FRCS,a Andre Brooks, MD,a John Stickley, BSc,a Steven M. Woolley, FRCS,a
Oliver Stu¨mper, PhD,b Timothy J. Jones, FRCS,a and William J. Brawn, FRCSa
Objective: We proposed that a right-sided right ventricle–pulmonary artery conduit during the stage I Norwood
procedure would facilitate pulmonary artery reconstruction during the stage II procedure.
Methods: Between 2002 and 2006, 153 patients underwent Norwood stage I reconstruction with a right ventri-
cle–pulmonary artery conduit (125 in the right-sided group and 28 in the left-sided group). The previous 150 con-
secutive classic Norwood procedures (1997–2002) were used as a control group. Outcomes from stages I and II
were analyzed, including ventricular function and pulmonary artery morphology.
Results: The 30-day survival was 88% (110/125) in the right-sided group, 75% (21/28) in the left-sided group,
and 70% (105/150) in the control group (P<.001, right-sided vs control groups). The conduit length was 35 9
mm in the right-sided group and 26 8 mm in the left-sided group (P¼ .001). Survival at 6 months demonstrated
a significant survival benefit in the right-sided right ventricle–pulmonary artery conduit group over the control
group (P ¼ .009, log-rank test). There was no difference in ventricular function between the groups and no re-
gional dyskinesia associated with the right ventricle–pulmonary artery conduit. Despite larger branch pulmonary
artery size in the right ventricle–pulmonary artery conduit groups (compared with the control group), central pul-
monary artery stenoses were common (62% in the right conduit and 80% in the left conduit). Bypass and ische-
mic times at stage II were 49  10 and 23  13 minutes in the right-sided group compared with 61.5  9.5 and
31 14 minutes in the left-sided group (P<.001 and P¼ .03, respectively). The 30-day mortality after the stage
II procedure was 1.3% (1/76) in the right-sided group, 0% (0/18) in the left-sided group, and 3.3% (3/90) in the
control group.
Conclusion: The right-sided conduit is a safe technique and has improved 30-day and overall post–stage II sur-
vival compared with that seen with the classic Norwood procedure. The right ventricle–pulmonary artery conduit
is associated with central pulmonary artery stenosis but good development of the branch pulmonary arteries and
preservation of ventricular function. The right-sided conduit significantly reduces cardiopulmonary bypass times
at stage II.The Norwood procedure has undergone a variety of modifi-
cations since its introduction in 1981,1 and outcomes have
steadily improved as a result of modifications of the surgical
technique combined with better preoperative and postopera-
tive management.2-5 In the recent era, the right ventricle–
pulmonary artery (RV–PA) conduit represents the single
most important development in surgical technique.
Although originally conceived by Norwood himself,6 the
conduit was reintroduced by Sano and colleagues7 in 2001
and has become widely adopted because of evidence of
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benefits include higher diastolic blood pressure, prevention
of retrograde diastolic flow in the aorta, and higher coronary
perfusion pressure when compared with the classical Nor-
wood procedure, in which the pulmonary blood supply is
through a systemic–pulmonary artery (PA) shunt. There
has also been evidence of improved growth of the central
PAs at the time of the stage II procedure.10,11
This institution changed to the RV–PA conduit technique
in 2002, routing the conduit to the leftward side of the neo-
aorta, according to previously described methods.7 Out-
comes were encouraging, but at the time of the stage II
operation, our institutional experience was that we found
that the central PAs frequently required patch repair at the
site of shunt insertion. This was a difficult and time-
consuming procedure because of the difficulty of mobilizing
the PA behind the neoaorta and across into the left side.
To try and avoid this difficult dissection at stage II, we
proposed a modification to the technique: routing the con-
duit to the right of the neoaorta (Figure 1), running into
the right PA such that access to the distal shunt and PAs at
stage II would be facilitated.rgery c September 2009




HLHS ¼ hypoplastic left heart syndrome
PA ¼ pulmonary artery
RV–PA ¼ right ventricle–pulmonary artery
The objective of this study was to analyze our experience
with these modifications of the Norwood procedure. Out-
comes were compared between the left-sided and right-sided
conduits to test our hypothesis that routing the RV–PA
conduit to the right of the neoaorta would facilitate PA
reconstruction during the stage II procedure. The groups
were compared with a matched group of patients undergoing
classical Norwood procedures from the most recent cohort
before the introduction of these modifications.
MATERIALS AND METHODS
All patients underwent the Norwood procedure for hypoplastic left
heart syndrome (HLHS) or associated conditions at a single institution,
the Diana Princess of Wales, Birmingham Children’s Hospital NHS Trust,
Birmingham, United Kingdom. The RV–PA conduit modification was
first performed in March 2002, and all patients undergoing the Norwood
procedure were included until the study end point in August 2006. During
this period, 153 patients were identified from the hospital database and
departmental records. Patients were divided into those receiving a right-
sided conduit (n ¼ 125) and those receiving a left-sided conduit (n ¼ 28).
The preceding 150 consecutive classical Norwood procedures performed
at this institution before the introduction of the RV–PA conduit were used as
a comparative group. These were performed between February 1997 and
March 2002. All patients undergoing the Norwood procedure were includedThe Journal of Thoracic and Cin the study, and the anatomic subtypes and patient characteristics are listed
in Table 1.
The study was a retrospective review that was registered with the Bir-
mingham Children’s Hospital R&D department; ethical approval was
applied for through the Central Office for Research Ethics Committees
but was waived after consultation in respect of relying on retrospective, ano-
nymized data. No patients were refused surgical intervention during the
study period.
Data were collected from patients’ records and from the departmental
electronic database (Heartsuite; Systeria, Inc, Glasgow, United Kingdom).
Preoperative characteristics were recorded as shown in Table 1. Operative
data included bypass and ischemic times and are summarized in Table 2.
Interstage mortality was recorded together with the operative details and
outcome of the stage II procedure. Follow-up was completed from patient
records.
All patients underwent cardiac catheterization before the stage II proce-
dure at 3 to 4 months of age. Angiograms were reviewed by one cardiologist
(OS) and one surgeon (AB). The reviewers documented ventricular function
(both global and segmental for areas of dyskinesia), central PA size, left and
right PA size at the hilum (defined as the point immediately before the first
branching point and expressed as a ratio of normal predicted values, accord-
ing to published techniques10,12,13), grade of tricuspid regurgitation, and
length of the conduit in the RV–PA groups. A significant PA narrowing
was defined as a decrease in the predicted size of 25% or greater.
Operative Technique
Much of the details of the operative technique and arch reconstruction
have been published previously.10 The techniques can be summarized as
follows. Deep hypothermic cardiopulmonary bypass was used with an
alpha-stat strategy, and antegrade cerebral perfusion has been used routinely
during arch reconstruction since 2002. Myocardial protection was achieved
with cold crystalloid cardioplegia (30 mL $ kg1). Arch reconstruction was
performed with a pulmonary homograft patch after excision of all duct tis-
sue and coarctation ridge (if present).FIGURE 1. Diagram showing the technical modifications of the Norwood procedure. A, The classical Norwood procedure with pulmonary blood supply
through a right Blalock–Taussig shunt. B, The RV–PA conduit passing to the left of the neoaorta, as described by Sano and colleagues.7 C, The right ventricle–
pulmonary artery (RV–PA) conduit passing to the right of the neoaorta. Ao, Aorta; SVC, superior vena cava; LPA, left pulmonary artery; PV, pulmonary vein;
RV, right ventricle; TV, tricuspid valve; IVC, inferior vena cava; PA, pulmonary artery. Reproduced with permission from the Journal of Thoracic and Car-
diovascular Surgery, 2006;131:418-26.ardiovascular Surgery c Volume 138, Number 3 529
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(classical Norwood procedure) P value
No. 125 28 150 –
Age at Norwood procedure (d) 4 (3–7) 6 (4–12) 4 (3–7) .01*
Weight (kg) 3.1  0.6 3.2  0.8 3.2  0.6 NS
BSA 0.2 (0.18–0.22) 0.2 (0.18–0.22) 0.2 (0.19–0.22) NS
Ascending aorta (mm) 3.0 (2.0–4.0) 3.2 (2.0–5.0) 3.2 (2.5–4.5) NS
Impaired RV function (%) 35.8 25 24.6 NS
Preoperative admission PICU (%) 50.4 57 57 NS
*Patients were comparable in all aspects other than age, in which the left RV–PA group was a median of 2 days older. RV–PA, Right ventricle–pulmonary artery; BSA, body surface
area; RV, right ventricular; PICU, pediatric intensive care unit.Control Subjects (Classical Norwood Procedure)
A 3.5-mm Gore-Tex shunt (W.L. Gore & Associates (UK) Ltd, Living-
ston, Scotland) was used in neonates weighing 2.5 kg or more, and a 3-mm
shunt was used if weight was less than 2.5 kg.
RV–PA Conduits
A 5-mm Gore-Tex conduit was used in neonates weighing 2.5 kg or
more, and a 4-mm conduit was used if weight was less than 2.5 kg. The ven-
triculotomy was made in the infundibulum of the right ventricle in a vertical
orientation for the left conduits and in a more diagonal–transverse orienta-
tion for the right conduits. The muscle edges were undermined to ensure
a wide opening beneath the proximal shunt, which was anastomosed to
the myocardium with a continuous 7-0 polypropylene suture (Figure 2).
For weaning from bypass, the inotrope delivery has changed during the
period of the study from 10 mg $ kg1 $ min1 dobutamine (until 2001)
to 0.5 mg $ kg1 $ min1 milrinone plus 0.05 to 0.2mg $ kg1 $ min1 epineph-
rine to maintain a systolic blood pressure of 60 to 70 mm Hg. A loading dose
of milrinone was not used. Epicardial echocardiographic analysis was used
routinely. The chest was routinely left open. The target arterial oxygen sat-
uration was 70% to 80%, with a mixed venous saturation of 40% to 50%.
Patients were discharged from the hospital on aspirin (5 mg $ kg1 $ d1) and
oral diuretic therapy. Patients with impaired right ventricular function or
clinically important systemic atrioventricular valvar regurgitation also re-
ceived an angiotensin-converting enzyme inhibitor.
Patients were electively catheterized at 12 to 15 weeks of age, with
the aim of performing the second-stage procedure at 4 to 6 months of
age. The exact timing was dependent on the patient’s clinical progress
and resting saturations. The second-stage procedure was a cavopulmo-
nary shunt (bidirectional Glenn procedure). In the RV–PA conduit
groups the conduit was ligated proximally but not excised from the heart.530 The Journal of Thoracic and Cardiovascular SuAny significant narrowing (>25% from predicted size) in the central PAs
was addressed at the time of the stage II procedure by using a pulmonary
homograft patch.
Statistical Methods
Data have been examined by using the statistical software package R
(version 2.4; R Foundation, Vienna, Austria). Continuous variables are
expressed as means (standard deviations) or medians (ranges), and compar-
ative univariable analyses have been made with the t test, the Tukey multiple
comparisons of means, or the Wilcoxon signed-rank test. Binomial or ordi-
nal data are expressed as percentages, and comparative univariable analyses
have been made with the 2-sided Fisher’s exact test. A probability value of
less than .05 was taken to represent a statistically significant difference
between groups.
Actuarial survival was estimated by using the Kaplan–Meier product-
limit method. These results have been expressed as probability estimates
(standard errors of the mean). Univariable analyses of actuarial outcome
measures have been made with the log-rank test.
RESULTS
In the entire patient group the mean weight was 3.2 0.6
kg, and the median age at the time of the operation was 4 days
(interquartile range, 3–7 days). The mean ascending aortic
size was 3.3 1.3 mm. The groups were comparable in terms
of patient characteristics. The patients in the left-sided group
were slightly older at the time of the operation than those in
the other groups (median, 6 vs 4 days), but weight and body
surface area were comparable (see Table 1).TABLE 2. Bypass details for the Norwood procedure and cavopulmonary shunt (stage II procedure) in the patient groups
Right-sided RV–PA conduit Left-sided RV–PA conduit
Control (classical
Norwood procedure) P value
Norwood procedure
CPB (min) 116  23 106  26 81  37 <.01, control vs RV–PA group*
AXC (min) 58  16 56  14 53  14 NS
DHCA (min) 20  16 22  16 51  14 <.01, control vs RV–PA group
Stage II procedure
CPB (min) 49  12 61  9 48  19 <.001, right-sided vs left-sided group
<.001, control vs left-sided group
AXC/DHCA (min) 23  13 31  14 19  11 <.03, right-sided vs left-sided group
<.01, control vs left-sided group
*The difference in CPB times is accounted for by the introduction of antegrade cerebral perfusion in the RV–PA conduit groups. If the cerebral perfusion times are incorporated into
the data, the difference ceases to be significant. RV–PA, Right ventricle–pulmonary artery; CPB, cardiopulmonary bypass time; AXC, aortic crossclamp time; DHCA, deep hypo-
thermic cardiac arrest time.rgery c September 2009
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iants of HLHS, including 5.5% (16/291) with unbalanced
atrial ventricular septal defects with right ventricular
dominance. A few (3.6%) of the patients had a Norwood
procedure for complex forms of right ventricular hypoplasia
(transposition of the great arteries with tricuspid atresia and
hypoplastic aorta and double-inlet left ventricle with trans-
position of the great arteries), but there was no difference
in the proportion of these patients between groups. None
of the patients in the ventricle–PA conduit groups had
a left ventriculotomy, with the conduit always being taken
from the right ventricle.
The bypass details are shown in Table 2 for both the stage
I and stage II procedures. The data for the stage I procedures
should be interpreted with respect to the fact that antegrade
cerebral perfusion was introduced in March 2002. Thus the
period of cardiopulmonary bypass was longer, and the deep
hypothermic circulatory arrest during arch reconstruction
was significantly reduced as a consequence of this. When
cerebral perfusion times were added into the analysis
(artificially adding them onto the DCHA time), then the
differences ceased to be significant. However, the total
crossclamp time was slightly greater in the RV–PA conduit
groups than in control group because of the additional period
required for the creation of the proximal conduit anasto-
mosis (P ¼ .05).
Overall 30-day survival for the Norwood procedure in this
study was 77.8%. The 30-day survival was 88% (110/125)
in the right-sided group, 75% (21/28) in the left-sided group,
and 70% (105/150) in the control group (P< .001, right-
sided vs control groups).
The length of the RV–PA conduit was 35  9 mm in the
right-sided group and 26  8 mm in the left-sided group
FIGURE 2. Operative photograph of the right-sided right ventricle–
pulmonary artery (RV–PA) conduit. The arch reconstruction and conduit
have been completed. The venous cannula is still in place in the right atrium,
and the arterial cannulation is through a 3-mm Gore-Tex shunt anastomosed
to the innominate artery.The Journal of Thoracic and C(P ¼ .001). There was no difference in mean saturations
(79%  7% vs 77%  10%) at the time of catheterization
between the classical and RV–PA conduit groups.
Follow-up was 100% complete over a median period of
15.7 months (range, 0.3–122 months). Of the 236 survivors
of the stage I procedure, 195 underwent the stage II proce-
dure, and a further 5 are awaiting the stage II procedure.
Interstage mortality was 11.8% overall. Within the study
groups, the interstage mortality was 14% in the right-sided
group, 11% in the left-sided group, and 10% in the control
group.
The overall pre–stage II survival was 74% (92/125) in the
right-sided group, 64% (18/28) in the left-sided group, and
60% (90/150) in the control group (P ¼ .02, right-sided vs
control groups). Kaplan–Meier actuarial survival curves are
shown in Figure 3. Although all groups demonstrated inter-
stage mortality, the survival benefit of the right-sided RV–
PA conduit seen after 30 days was maintained throughout
the study period. Regression analysis for the right-sided
group showed improved survival over the classical Nor-
wood procedure (P ¼ .009, control group) at 6 months.
There was no difference demonstrable between the left-sided
RV–PA conduit group and the control group.
A total of 130 pre–stage II angiograms underwent detailed
review, and only those performed at other institutions were
excluded. There was no difference in the proportion from
each group studied.
Ventricular function was normal or mildly impaired in
85.9% (59/65) of the right-sided group, 76.4% (13/17) of
the left-sided group, and 85.2% (40/47) of the control group.
FIGURE 3. Kaplan–Meier survival curves after the Norwood procedure
performed with the classical technique (right modified Blalock–Taussig
shunt) or with a left- or right-sided right ventricle–pulmonary artery (RV–
PA) conduit. The right-sided RV-PA conduit group had significantly better
survival at 30 days and 6 months (P ¼ .009) when compared with those
undergoing the classical Norwood procedure.ardiovascular Surgery c Volume 138, Number 3 531
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DFIGURE 4. Angiogram still images after the stage I Norwood procedure showing the right ventricle–pulmonary artery (RV–PA) conduits and pulmonary
arteries. A, Examples of the left-sided conduit. Central pulmonary artery stenoses were common and required patching at stage II in 83%. B, Examples of the
right-sided conduits. Central stenoses (see image on the right) were common, although access from the right side was facilitated by the shunt position. Note
that the right-sided conduits take a longer course than the left-sided conduits.This difference was not statistically significant (P ¼ .07).
There was no evidence of regional wall dyskinesia (specifi-
cally of the anterior free wall) associated with the RV–PA
conduit groups. Examples of the angiograms are shown in
Figure 4.
PA sizes are summarized in Figure 5. Any diameter of
less than 25% of predicted size was regarded as signifi-
cant. Central PA narrowing was commonly seen in both
the RV–PA conduit groups (mean diameter of 0.65 
0.29 in the left-sided group and 0.75  0.41 in the
right-sided group compared with 1.2  0.31 in the control
group, P < .001). Although the incidence of narrowing
was slightly worse in the left-sided group (80% vs
62%), there was no significant difference between those
of the right- and left-sided groups.
In contrast, the branch PA sizes were larger in the RV–PA
conduit groups than in the control group (2.51 and 2.52 for the
RV–PA conduit groups vs 2.31 for the control group,P<.01),
with the greatest benefit seen in the left PA (1.27 and 1.19 vs
1.01, respectively; P< .01). Again there was no difference
between the 2 RV–PA conduit groups; both had larger branch
PAs than the control group (Figure 5, A and B).
The stage II procedure was performed at a median age of
22 weeks (interquartile range, 18–26 weeks). Outcome from
the stage II procedure was similar in all groups. There was no
incidence of shunt injury at resternotomy, and all patients532 The Journal of Thoracic and Cardiovascular Surwere started on bypass in a routine fashion. The 30-day mor-
tality was 1.3% (1/76) in the right-sided group, 0% (0/18) in
the left-sided group, and 3.3% (3/90) in the control group.
The single death in the RV–PA conduit groups was of
a patient with severe tricuspid regurgitation and an impaired
right ventricle. Ventricular function remained impaired
postoperatively, with high PA pressures, and the patient
could not weaned from ventilatory support despite reversing
the cavopulmonary shunt on day 17.
Narrowed central PAs were enlarged with a patch of pul-
monary homograft at the time of the stage II procedure,
where necessary. The majority of the patients receiving
RV–PA conduits required patching, as defined above. Car-
diopulmonary bypass time was 49  12 minutes in the
right-sided group compared with 61  9 minutes in the
left-sided group and 48  29 minutes in the control group
(P< .005, right-sided vs left-sided groups). Ischemic times
(combined aortic crossclamping and deep hypothermic cir-
culatory arrest) were also significantly longer in the left
RV–PA conduit group (31 14 minutes vs 23 13 minutes
in the right-sided group and 19  11 minutes in the control
group, P< .01).
Survival curves at 6 months after the stage I Norwood pro-
cedure demonstrate a survival benefit in the RV–PA group
compared with those undergoing the classic Norwood pro-
cedure (P ¼ .009, log-rank test).gery c September 2009
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DFIGURE 5. Box plots showing the distribution of pulmonary artery size in
the 3 groups of patients at the time of the stage II procedure. Each box rep-
resents the interquartile range, and the solid line in each box shows the mean
value. All values were expressed as a normalized value according to the
patients’ weight and body surface area. A, Right pulmonary artery sizes.
There was no difference between groups. B, Left pulmonary artery sizes.
Both right ventricle–pulmonary artery (RV–PA) conduit groups had larger
left pulmonary arteries than the control group (P< .01). There was no dif-
ference between the 2 RV–PA conduit groups. C, Narrowest diameter of
confluence. Both RV–PA conduit groups had a greater degree of central ste-
nosis than the control group (P<.01). There was no difference between the
2 RV–PA conduit groups.The Journal of Thoracic and CDISCUSSION
The RV–PA conduit has attracted a great deal of interest
as a technical modification of the classical Norwood proce-
dure. The concept was originally proposed by Dr Norwood
himself in the 1980s, but no suitable conduits were believed
to be available.6 The advantage of providing PA flow
through an RV–PA conduit rather than with a systemic shunt
has been shown to be the maintenance of systemic diastolic
pressure, reducing reversed aortic flow during the diastolic
phase.8-10,14 However, concerns with the technique include
the need for a ventriculotomy with consequent impairment
of ventricular function and a risk of ventricular arrhythmias.
Graham and colleagues11 recently compared ventricular
function in patients receiving an RV–PA conduit and those
undergoing the classical Norwood procedure and could not
demonstrate any difference. These findings support those
described in this study in that we could find no difference
in global right ventricular function or in anterior wall motion
within the RV–PA groups and the control group. A second
potential problem with the RV–PA conduit is that there is
also a degree of regurgitation that might volume load the
ventricle. This has already led to the consideration of the
use of small homografts to provide a competent valve as
the RV–PA conduit.15
As a consequence of these arguments, the RV–PA conduit
has not been adopted universally. The debate is further com-
plicated by parallel advances in operative and perioperative
management, which continue to improve the outcomes of
the procedure. These have included changes in bypass tech-
niques, such as the introduction of antegrade cerebral perfu-
sion during arch repair (although this has still not always
been shown to influence survival outcomes), and a trend
toward smaller shunt sizes to protect against pulmonary
overcirculation.16,17 A shift of focus from manipulating
the pulmonary vascular resistance to the sustained reduction
in systemic vascular resistance has also improved postoper-
ative management,3,5 and it has been difficult to measure the
effect of each of these individual factors on the improving
overall outcomes of the past few years.3,18
We previously reported our early experience with the
RV–PA conduit and demonstrated a survival benefit in com-
parison with the classical procedure at our institution.12
However, when assessing left-sided RV–PA conduits for
the stage II procedure, there was frequently significant cen-
tral narrowing in the PAs. This resulted in the stage II oper-
ation requiring considerable mobilization and surgical
dissection over to the leftward side.10
Difficulties with the stage II procedure have not been
a major feature of recent publications, although most have
focused on events surrounding the first stage. However, out-
comes from the stage II procedure have not been without
incident (8% mortality in Sano and colleagues’ original
series4), and the need for extensive leftward mobilization ofardiovascular Surgery c Volume 138, Number 3 533
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cation). Ballweg and coworkers19 recently described a 58%
incidence of central PA stenoses and hypoplasia associated
with the left-sided RV–PA conduit. It was for this reason
that we proposed bringing the RV–PA conduit to the right
of the reconstructed aorta to make access to the shunt and
PAs much easier at stage II and avoid the need to have to
approach the PAs to the left of the neoaorta. A rightward
course of the conduit has been cited recently by other au-
thors,20 but the 2 variants have not previously been compared.
The results confirm that the right shunt significantly
reduced the bypass and ischemic times for the stage II pro-
cedure. From a surgeon’s viewpoint, any reconstruction of
the PAs was far more accessible and easier to perform.
The PAs themselves developed very well in all the RV–
PA conduit groups and support our previous observations
that the technique is associated with excellent branch PA
growth, particularly of the left PA, which can become rela-
tively hypoplastic in the setting of a classical shunt proce-
dure. Although the size of the branch PAs alone is only
one of many factors that influence outcome with the Fontan
circulation, this is certainly an important consideration in the
Norwood procedure and something that can be influenced
by surgical technique. It is encouraging that the right-sided
RV–PA conduit was associated with similar improved
development of the left PA, despite the position of the shunt
being somewhat more distant from the left lung. Patch aug-
mentation of the central PAs was still frequently required
(62% to 80% of cases), but access was straightforward
from the right side.
The unexpected finding in this study was the survival ben-
efit of the right-sided conduit over the original, left-sided
Sano conduit. There were no differences in terms of bypass
and ischemic times. The only technical difference that we
demonstrated was that the right-sided conduit is naturally
longer than when placed to the left (a mean of 9 mm longer),
which would provide a greater fixed resistance to pulmonary
blood flow and also reduce the regurgitant fraction imposed
on the right ventricle. The data do not permit any further
analysis of the shunt characteristics, and these are only spec-
ulative reasons as to why this might have a hemodynamic
advantage. We have not demonstrated any difference in
arterial oxygen saturation between the left- and right-sided
groups, but this has been shown to be a poor indicator of
Qp in the setting of the Norwood circulation, where systemic
oxygen delivery (Qs) and oxygen extraction might have
a more important role.18 Sternal re-entry was not hazardous,
despite the anterior position of the proximal conduit. This
was partly helped by the routine placement of a Gore-Tex
pericardial membrane at the time of chest closure after the
stage I procedure.
One of the greatest concerns regarding these outcomes is
the consistent attrition between hospital discharge after the
stage I procedure and completion of the stage II procedure.534 The Journal of Thoracic and Cardiovascular SuInterstage mortality has been a feature of most programs
for HLHS in which interstage mortality has commonly
ranged between 9% and 16%.3,5,21,22 The cause of
interstage mortality has not been fully elucidated, and a sub-
stantial proportion remains sudden and unexpected.23
Ghanayem and colleagues24 reported complete interstage
survival after the introduction of a ‘‘home surveillance pro-
gram’’ that enabled at-risk patients to be identified and
treated aggressively. Home monitoring of pulse oximetry
and close inpatient surveillance have both been suggested
to reduce risk and been shown to be successful. A detailed
analysis of the interstage deaths might help identify risk fac-
tors but was beyond the scope of this study; nevertheless, the
sustained survival benefit of the RV–PA conduit beyond
stage II remains an important observation.
The retrospective design of this study limits the power of
any inferences that are made regarding the superiority of
one technique over another. It is possible that the results
of the left-sided conduit would have improved with experi-
ence if the technique had been continued. The data cannot
answer this, but the evidence that even the left-sided group
showed an immediate improvement25 over the classical
group would suggest that technical issues were not a major
factor. The improved survival could equally be interpreted
as being due to the effect of era on outcomes, but we be-
lieve this is unlikely in view of the stepwise change in mor-
tality seen with introduction of the RV–PA conduit. Our
previous studies of Norwood outcomes have not suggested
that era was a strong factor in outcome.12 The technique is
an example of one modification spawning another, the dan-
ger being that too many options make it increasingly diffi-
cult to verify and analyze individual techniques. As we
await the results of a randomized trial of the classical
versus RV–PA conduit, this article potentially adds a new
variation for consideration. We can only argue that surgical
intervention for HLHS is a constantly evolving field in
which rapid advances are being made but in which there
is still no standard management and in which problems
have to be dealt with as they arise.
In conclusion, the RV–PA conduit is a safe technique that
does not seem to impair ventricular function and that confers
a survival benefit up to at least 6 months of life after
Norwood stage I reconstruction. The right-sided conduit
facilitates repair at stage II and appears to confer a survival
benefit after the stage I procedure over that seen after the
classical Norwood procedure that we could not demonstrate
with the left-sided conduit. This might be related to the lon-
ger length of the conduit used. A high incidence of central
PA stenosis occurred with the RV–PA conduits, but PA
reconstruction at stage II is greatly facilitated if the RV–
PA conduit is routed to the right of the neoaorta.
We thank Drs Simon McGuirk and Elizabeth Rumball for their
help with the data collection and Dr Paul Davies for statistical advice.rgery c September 2009
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Discussion
Dr Shunji Sano (Okayama City, Japan). I congratulate
Dr Barron and his group on their excellent results. They presented
the results of first-stage palliation of HLHS. Their experience with
153 patients over a 4.5-year period shows a 30-day mortality of
12% on right-sided RV–PA, 25% on the left side, and 30% in the
control group. They also demonstrated a significant survival benefit
in the RV–PA group. No difference in ventricular function was
seen between groups. No regional dyskinesia was associated with
the RV–PA shunt. Central PA stenosis has the advantage of an
RV–PA shunt, especially on the left side.
Since 1998, 61 consecutive patients underwent RV–PA shunts
in our unit, and all patients had a left-sided RV–PA shunt. Our
30-day mortality is 6.6%, and 6-month mortality is 10%. Forty-
seven patients underwent the bidirectional Glenn procedure, and
PA plasty was required in 17 patients. Fourteen patients underwent
Hegar dilation only through a bidirectional Glenn anastomosis site.
Only 3 patients required patch angioplasty. Twenty-nine patients
have reached Fontan compression, with 8 patients requiring PA
plasty. Some of them had Hegar dilation only, and only 1 patient
required patch aortoplasty. Therefore of 61 patients, only 4 required
patch aortoplasty, and all 4 patients had reconstructed distal PA
stumps with autologous pericardium.
Therefore we changed our technique of distal PA anastomosis by
using a polytetrafluoroethylene cuff graft, which is already
reported. Since then, we have had no patients who required PA
patch aortoplasty.
As long as pulmonary blood flow is through an RV–PA shunt,
theoretically, there is not much difference if the shunt is right or
left sided. The reasons why I do RV–PA shunts to the left side
are that a left-sided shunt looks natural, it does not cross the aorta,
and the RV–PA shunt could be left open at the time of the bidirec-
tional Glenn procedure as additional flow if the PA is small, espe-
cially the left side.
I have a few questions for Dr Barron. First, I think everyone is
worried about compression of the graft if the graft crossed the neo-
aorta. Did you find any stenosis or obstruction in the graft?
Dr Barron. Thank you very much, Dr Sano. I should be stand-
ing here congratulating you over your results, too.
I think that you make a very valid point. All we can say is that we
have not encountered it as being a major problem because I think it
concerned us, too. We used delayed sternal closure, and we would
not close the chest until a patient had been in a persistent negative
fluid balance so that any of the original cardiac swelling had disap-
peared. Therefore we were not seeing acute obstruction to the shunt
when the chest was closed.ardiovascular Surgery c Volume 138, Number 3 535
Congenital Heart Disease Barron et al
C
H
DIn terms of follow-up, we have only been conscious of seeing it
in 2 of 125 patients who have had the RV–PA shunt inserted, and
those 2 patients have both been treated with a coronary stent placed
at the time of catheterization to just buy extra time until the opera-
tion. Therefore I cannot say that we have been conscious of it being
a major issue with the patients.
Whether some of the interstage mortality was related, it is very
difficult for us to analyze interstage death, which is very frustrating,
but the histories of the patients would not suggest a thrombosis of
the shunt.
Dr Sano. In your article a central PA stenosis was 80% at the left
side and 62% at the right side. To me, the late or center pulmonary
stenosis is quite different from our experience. Could you describe
your technique of left-sided PA reconstruction. Also, you anasto-
mosed a shunt directly to the PA still with significant PA stenosis.
Therefore did you change your technique of distal PA anastomosis
to avoid PA stenosis?
Dr Barron. We certainly recognize that we are seeing a high
incidence of PA stenosis and that it has not been reported by every-
body, and we do not quite understand why that should be.
Clearly, I think other centers have experienced this problem with
the PAs, and we can say that we are certainly aware of centers who
regard it as such a significant problem that they have reverted back
to doing the classical Norwood procedure because they were find-
ing it difficult to manage these cases.
In terms of whether we changed our technique, we did try chang-
ing. We tried putting a patch first into the PAs and then putting
a shunt into the patch or putting the shunt directly into the PAs.
But we could not demonstrate any improvement. Although there
is a very high incidence of narrowing in the PA, many are only rel-
atively narrow. I am not sure whether everybody would consider
them meriting too much attention, but we would regard anything
more than a 25% reduction in diameter as requiring attention at
the time of the operation.
In terms of our technique for doing it, we would open the artery
as far as we could out into the hilum of the lung and repair it with
a PA patch.
Dr Sano. Finally, we reported that regurgitant flow ratio through
a 5-mm graft is 26% by using color Doppler echocardiographic
analysis. Did you measure regurgitant flow ratio in your series,
and was there any difference in the right-sided and left-sided shunts?
Dr Barron. The simple answer is that we did not, but it would be
very interesting to know that. Because, as you say, it might be that
some of the advantage of that longer shunt is that it reduces the
regurgitant fraction because the back resistance is that little bit
higher. But we did not measure it.
Dr Sano. I will just mention that the RV–PA shunt procedure
started only 9 years ago, and with refinement of the procedure,
the result has been proved in many institutions. I must say the
PA reconstruction is not easy, and we need more refinement.
Finally, I congratulate your excellent results and beautiful pre-
sentation, and I must thank the association for giving me the oppor-
tunity to discuss this important article.
DrArdawan Rastan (Leipzig, Germany). I appreciate your pre-
sentation very much, and it was really interesting. You have a huge
experience in these really demanding patients.
I have 2 questions. First, do you have any experience with
valved conduits? Second, do you have any experiences with or536 The Journal of Thoracic and Cardiovascular Sudo you have any problems with reoperations for stage II? Do you
have any injuries of the shunts, and do you have any protocols to
avoid any adhesions for these patients?
Dr Barron. We do not use valved conduits. I would be very
interested to see Dr Hanley’s series recently published using small
homografts in these patients, and certainly you could see the
hemodynamic benefits that might have. The simple truth is that
we do not have access to this type of small homograft in sufficient
numbers that we could use valved conduits, and therefore we have
not.
We have not had any problem in resternotomy in these patients.
It worried us going straight in with the conduit being very anterior.
I think the use of a pericardial Gore-Tex membrane has been very
helpful, but we have not had a single episode of injuring a heart on
reopening the sternum, and all the patients were started on bypass in
a routine fashion.
Dr James S. Tweddell (Milwaukee, Wis). Thanks, this was an
excellent study and an excellent presentation.
I think we actually do this in a way very similar to your tech-
nique. We also bring the conduit to the right side. I think the differ-
ence—and this might be important—is that we routinely patch the
distal pulmonary confluence. I also fully mobilize the PAs from
first branch to first branch to place the native PA segment actually
to the right of the ascending aorta as well.
I think that this was brought up as a potential factor last week at
the World Society of Pediatric and Congenital Heart Surgery. I do
not always remember who the author was, Jeff. Therefore it might
be that patching and the right-sided position are important. But
I thought your article was excellent and I just rise to add those 2
potential comments of ways to modify the technique.
My question is concerning your stage II strategy. Do you rou-
tinely clamp for that, and what is the need for that?
Dr Barron. Thank you.
In terms of patching the PAs, I am intrigued by patching the
PAs because it seems to make sense that we should be patching
them all. But when we analyzed this—we published our data last
year simply looking at patching the PAs at the time of the stage I
procedure (it was in a more historical cohort before the RV–PA
conduits)—we could not demonstrate that patching them or not
patching them, by closing the PAs directly, seemed to have
any influence on the morphology of the PAs afterward. We can-
not really explain that. I wonder whether there is such limited
room sometimes in the concavity of the arch underneath the re-
constructed aorta that the left PA gets kind of trapped a little be-
hind it and whether sometimes putting a patch in simply leaves
you too much tissue in there and the thing just gets folded and
caught between it.
Dr Tweddell. Well, I think you should put the distal conduit into
the patch.
Dr Barron. Into the patch. That might be a good point. And you
had a second question?
Dr Tweddell. Concerning the stage II procedure.
Dr Barron. It has been our policy—and that might be a rather
aggressive policy—that we tend to cool the patients right down
at stage II unless they have very straightforward anatomy and
have routinely used a period of circulatory arrest to reconstruct
the PAs and form the anastomosis. I think it is our philosophy
that we just want to make sure we get the PAs as good as wergery c September 2009
Barron et al Congenital Heart Disease
C
H
Dpossibly can and get the best possible view and get them to their
maximum size.
Dr Emile A. Bacha (Boston, Mass). I have a comment and
a question.
Do you think the improved survival that you have shown is
a matter of a learning curve? It seems to me over the last few years
that you have been using a right-sided conduit and before that you
were using a left-sided conduit.
Dr Barron. Yes, there is no doubt that because the design is
a retrospective study with a historical control, it could well be.
What we could say is that we saw an immediate improvement in
our survival figures when we undertook the left RV–PA conduit.
Therefore that was early evidence that the hemodynamic benefit
was there straightaway and maybe there was not too much of
a learning curve.
Dr Bacha. The reason I am asking is that we also in Boston
mostly are doing a right-sided RV–PA conduit, and we have not
seen a change in survival, but we have definitely seen the greater
facility at stage II.The Journal of Thoracic and CThe comment I was going to make is that this conduit crossing
from the left to the right underneath the sternum can be trouble-
some sometimes in a stage II procedure. We have 2 patients
who had their stage I procedures at our institution and went on
to have a stage II procedure at another institution who both died
at the time of the redo operation when the surgeon sawed into
the conduit, and it is a difficult situation, and in a small baby, to
rescue these kids.
Dr Vaughn A. Starnes (Los Angeles, Calif). I have 1 quick
question. Did you notice a differential in time between when you
did your stage II procedure, in left versus right, as an indicator of
quality of shunt?
Dr Barron. No, there is no difference in time. Our mean time
is 22 weeks. What we have found is that we do the stage II pro-
cedure in the entire RV–PA conduit group slightly earlier than
we were doing it in the classical Norwood procedure group. I
think that is partly because we were anxious to see the anatomy
early on when we started the procedure, and it has just kind of
stuck with us.ardiovascular Surgery c Volume 138, Number 3 537
